FDA expands Allergan ' s Vraylar for bipolar depression treatment

Vraylar is also approved for schizophrenia in adults and for manic or mixed episodes associated with bipolar I disorder
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news